CLAIM #3125 · Abbott Laboratories (ABT) · 2024Q1 earnings call · Apr 17, 2024 · due Dec 31, 2024
“We are very well-positioned to continue to deliver strong results for the remainder of the year”
Robert Ford · CEO
PENDING
graded after results covering Dec 31, 2024 are reported
Verify independently
SEC filings for ABT ↗ · Claim quote is verbatim from the 2024Q1 earnings call.